R&D and core team leader with fifteen years experience developing products and leading multidisciplinary teams in the IVD and life science industries - Worked at three successful startups in roles with increasing responsibility - Extensive experience in managing high value projects with outside partners, including engineering design firms and contract manufacturers - Excellent problem solving skills – highly analytical and detail oriented, with demonstrated ability to work under time pressure - Extensive experience in surface science and deposition of biological material on silicon, gold, glass, and polymeric surfaces - Broadly skilled in the design and implementation of mechanical, fluidic, and optical systems, as well as in assay development/validation, and whole blood separations - Extensive experience in product verification/validation testing, project planning, and execution - Experienced in FDA design control requirements, including risk management and hazard analysis for medical devices - Publications include twelve issued patents, four published patent applications, and four articles in peer-reviewed journals
No project created yet.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.